Ramy Farid
Vorstandsvorsitzender bei SCHRÖDINGER, INC.
Vermögen: 51 Mio $ am 31.05.2024
Profil
Ramy Farid hat die Position des President, Chief Executive Officer & Director bei Schrdinger, Inc. inne. Er ist auch im Vorstand von Nimbus Therapeutics LLC, Morphic Therapeutic, Inc. und Ajax Therapeutics, Inc. tätig. Zuvor hatte er die Position eines Assistenzprofessors an der Rutgers State University of New Jersey inne. Er erhielt einen Doktortitel von der University of Pennsylvania und einen Doktortitel vom California Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.04.2024 | 4 085 495 ( 2,92% ) | 47 Mio $ | 31.05.2024 | |
SCHRODINGER, INC.
0,29% | 01.04.2024 | 184 432 ( 0,29% ) | 4 Mio $ | 31.05.2024 |
VIR BIOTECHNOLOGY, INC.
0,01% | 29.05.2024 | 16 000 ( 0,01% ) | 164 320 $ | 31.05.2024 |
Aktive Positionen von Ramy Farid
| Unternehmen | Position | Beginn |
|---|---|---|
| SCHRÖDINGER, INC. | Vorstandsvorsitzender | 01.01.2017 |
| STRUCTURE THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.04.2019 |
| VIR BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 29.05.2024 |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ajax Therapeutics, Inc. operates as a biomedical company. The company is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - |
Schrodinger, Inc. (Oregon)
 Schrodinger, Inc. (Oregon) Packaged SoftwareTechnology Services Schrodinger, Inc. is a private company based in Portland, OR. The company develops a drug discovery platform. | Präsident | - |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 12.04.2022 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ramy Farid
| Unternehmen | Position | Ende |
|---|---|---|
| MORPHIC HOLDING, INC. | Direktor/Vorstandsmitglied | 01.06.2019 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Ramy Farid
| Rochester Christian University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
| California Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| SCHRÖDINGER, INC. | Technology Services |
| MORPHIC HOLDING, INC. | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Private Unternehmen | 7 |
|---|---|
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Health Technology |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ajax Therapeutics, Inc. operates as a biomedical company. The company is headquartered in New York, NY. | Health Technology |
Schrodinger, Inc. (Oregon)
Schrodinger, Inc. (Oregon) Packaged SoftwareTechnology Services Schrodinger, Inc. is a private company based in Portland, OR. The company develops a drug discovery platform. | Technology Services |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
